Complete Mounjaro to Wegovy Dose Comparison & Conversion
Understanding Mounjaro to Wegovy Dose Conversion Chart Fundamentals
The Mounjaro to Wegovy dose conversion chart reveals significant differences in both dosing schedules and active ingredients that patients must understand before transitioning. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist, whilst Wegovy contains semaglutide, targeting GLP-1 receptors exclusively. Mounjaro's dosing begins at 2.5mg weekly and can escalate to 15mg, whereas Wegovy starts at 0.25mg and reaches a maximum maintenance dose of 2.4mg. These medications cannot be directly converted on a milligram-to-milligram basis due to their different molecular structures and receptor binding profiles.
When consulting our Mounjaro to Wegovy dose conversion chart, prescribers consider individual patient response, tolerability, and therapeutic goals rather than simple numeric equivalents. The timing of dose escalation also differs significantly—Mounjaro typically increases every four weeks through six dose levels, whilst Wegovy follows a five-stage escalation over sixteen weeks. Both prescription-only medicines require careful medical supervision during any transition period. Your clinical assessment will determine the appropriate starting dose based on your previous treatment response and current health status.
Comprehensive Pricing Comparison for Mounjaro to Wegovy Conversion
Our Mounjaro to Wegovy dose conversion chart includes transparent pricing to help patients understand the financial implications of switching treatments. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Bundle options provide convenience for extended treatment periods, such as our Intro Trio (0.25mg, 0.5mg, and 1mg) for £299.99. New customers benefit from discount code FIRST40 applied at checkout, whilst returning customers use code DOSE25 to reach these final pricing levels.
The cost comparison within our Mounjaro to Wegovy dose conversion chart demonstrates different pricing structures reflecting the medications' distinct formulations and manufacturing processes. Our Getting Started Bundles, including the Progress Duo (0.5mg and 1mg) for £189.99, ensure seamless dose escalation without multiple orders. Consistency bundles provide maintenance supply security, such as Consistency 2.4mg (×2) for £419.99 for patients established on maximum dosing. Both treatments are available through our streamlined ordering process with prescriber review typically completed within three working days, or express 24-hour review when required.
Clinical Evidence Supporting Mounjaro to Wegovy Dose Conversion Decisions
The Mounjaro to Wegovy dose conversion chart must be interpreted alongside robust clinical evidence from respective trial programmes. Wegovy's efficacy was demonstrated in the STEP trial series, with STEP 1 showing approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo when used alongside diet and exercise (Wilding et al., NEJM, 2021). STEP 5 confirmed sustained weight management benefits at two years, whilst the SELECT trial revealed 20% reduction in major cardiovascular events. These results support Wegovy's position in comprehensive weight management programmes under medical supervision.
When reviewing our Mounjaro to Wegovy dose conversion chart, prescribers consider individual patient factors beyond trial averages, as real-world responses vary significantly. Clinical trials provide valuable guidance, but individual outcomes depend on adherence to reduced-calorie diets, increased physical activity, and consistent medication administration. Both medications require ongoing medical monitoring and lifestyle modifications to achieve optimal results, making prescriber guidance essential during any treatment transition.
How Wegovy's GLP-1 Mechanism Differs in Dose Conversion Planning
Understanding Wegovy's mechanism is crucial when interpreting any Mounjaro to Wegovy dose conversion chart, as semaglutide works exclusively through GLP-1 receptor agonism. This natural hormone pathway regulates appetite by promoting satiety signals in the brain's appetite control centres, helping patients feel fuller after smaller meals. The medication may reduce food cravings and slow gastric emptying, contributing to sustained appetite control throughout the week. Wegovy's once-weekly FlexTouch pen delivery system maintains consistent therapeutic levels, supporting reliable appetite regulation. Unlike dual-receptor medications, Wegovy's focused GLP-1 targeting provides a well-established mechanism with extensive clinical experience across multiple therapeutic areas.
Streamlined Ordering Process for Mounjaro to Wegovy Conversion
Accessing treatments featured in our Mounjaro to Wegovy dose conversion chart requires completion of our comprehensive three-minute online clinical assessment covering medical history, current medications, and treatment goals. Our qualified prescribers review each application within standard three working days, with express 24-hour review available when clinically appropriate. Once approved, medications are dispatched via next-day delivery using specialised cold-chain transport maintaining required 2-8°C temperatures throughout transit. Each order includes detailed administration guidance, dose escalation schedules, and direct access to our clinical support team for ongoing queries. Our GPhC-registered pharmacy (#9012878) ensures all medications meet stringent UK quality standards and regulatory requirements.
Storage and Practical Considerations in Mounjaro to Wegovy Conversion
The Mounjaro to Wegovy dose conversion chart includes important storage differences that patients must understand for successful treatment transition. Wegovy requires refrigerated storage at 2-8°C before first use but offers superior travel flexibility with six weeks room temperature stability below 30°C once removed from refrigeration. This advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for patients with frequent travel requirements or varied lifestyle patterns. The FlexTouch pen system provides reliable dose delivery with clear dosing windows and automatic needle safety features. Patients must never skip doses during the escalation schedule, as this mandatory progression ensures optimal tolerability and therapeutic effectiveness throughout the treatment journey.
Individual Response Patterns in Mounjaro to Wegovy Dose Conversion
Our Mounjaro to Wegovy dose conversion chart recognises that patient responses vary significantly based on individual factors including metabolic rate, previous treatment history, and genetic variations in drug metabolism. Some patients may experience different tolerability profiles when transitioning between medications, requiring careful dose titration and monitoring periods. The conversion process typically involves starting Wegovy at the appropriate escalation dose rather than attempting direct milligram equivalency with previous Mounjaro dosing.
Successful implementation of any Mounjaro to Wegovy dose conversion chart depends on comprehensive medical review and individualised treatment planning rather than standardised protocols. Factors including concurrent medications, underlying health conditions, and previous adverse event history all influence optimal conversion strategies. Our clinical team provides personalised guidance throughout the transition process, ensuring each patient receives appropriate support for their specific circumstances and therapeutic goals.
Expert Support for Mounjaro to Wegovy Dose Conversion Success
Implementing our Mounjaro to Wegovy dose conversion chart successfully requires ongoing clinical support and patient education throughout the transition process. Both treatments are available through EverydayMeds with competitive pricing, convenient bundle options, and comprehensive prescriber support to help determine which medication best suits your individual circumstances and treatment goals. New customers benefit from discount code FIRST40 whilst returning customers use DOSE25, both applied at checkout to reach our transparent final pricing. Our clinical team remains available for ongoing support, dose adjustment guidance, and any questions arising during your weight management journey. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discuss which treatment option may be most suitable for your needs with our qualified prescribers.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
